Refine
Year of publication
Document Type
- Doctoral Thesis (44)
- Diploma Thesis (3)
Has Fulltext
- yes (47)
Is part of the Bibliography
- no (47)
Keywords
- Metabolic Engineering (2)
- Saccharomyces cerevisiae (2)
- yeast (2)
- 3-alkylphenols (1)
- 6-methylsalicylic acid synthase (1)
- ALE (1)
- Anabolismus (1)
- Biosynthese (1)
- Biotechnologie (1)
- Biotechnologische Industrie (1)
- EMCP (1)
- Fatty Acid Synthase (1)
- Fatty Acids (1)
- Gal2 (1)
- Haloferax volcanii ; Stoffwechsel ; Analyse ; Halobacterium salinarium ; Zellzyklus (1)
- Hefe (1)
- Hefeartige Pilze (1)
- Isoprenoide (1)
- Limonene-3-hydroxylase (1)
- Lipidmembran (1)
- Membranlipide (1)
- Metabolon (1)
- Methanol (1)
- Methylobacterium (1)
- Methyltransferase (1)
- Microbiology (1)
- Molekularbiologie (1)
- Monoterpenoid (1)
- Monoterpenoid tolerance (1)
- Non-canonical terpenes (1)
- Pichia ciferrii (1)
- Prenyl pyrophosphates (1)
- Pseudomonas putida (1)
- SCO2 (1)
- Sphingolipide (1)
- Sphingosin (1)
- TIGAR (1)
- TKTL1 (1)
- Terpenes (1)
- Terpenoid (1)
- Tocochromanol (1)
- Transport (1)
- Truffle (1)
- Xylose (1)
- Yeast (1)
- arabinose (1)
- aroma (1)
- cell death (1)
- consortia (1)
- cooperation (1)
- fitness (1)
- fungi (1)
- genetical engineering (1)
- genotype (1)
- glioma (1)
- metabolism (1)
- microbiome (1)
- p53 (1)
- polyketide synthase (1)
- rationale Stammentwicklung (1)
- sphingolipids (1)
- sphingosine (1)
- sugar uptake (1)
- tsetse fly (1)
- xylose (1)
Institute
- Biowissenschaften (46)
- Biochemie und Chemie (1)
Die Hefe Saccharomyces cerevisiae hat sich wie kaum ein anderer Organismus auf die Verwertung von Glukose spezialisiert. Die Aufnahme dieser Hexose stellt dabei den ersten Schritt der Metabolisierung dar. Saccharomyces cerevisiae besitzt hierfür eine große Zahl an Hexosetransportern und eignet sich daher gut zur Untersuchung der Wirkungsweise und Regulation dieser Transporter, sowie deren Translokation zur Plasmamembran.
Ziel der vorliegenden Arbeit war es, die Funktion des in der Membran des Endoplasmatischen Retikulums lokalisierten Proteins Gsf2 der Hefe Saccharomyces cerevisiae näher zu charakterisieren. Gsf2 ist an der Translokation der Hexosetransporter Hxt1, Hxt3 und Gal2 zur Plasmamembran beteiligt. Die Deletion von GSF2 führt zur Akkumulation dieser Transporter in der Membran des Endoplasmatischen Retikulums. Interaktionen von Gsf2 mit ribosomalen Proteinen, Komponenten der Translokationsmaschinerie und COPII-Hüllproteinen deuten auf eine multifunktionelle Hexosetransporterspezifische Funktion des Verpackungschaperons Gsf2 hin.
Mit Hilfe des „Synthetic Genetic Arrays“ wurde nach synthetisch letalen und synthetisch kranken Interaktionspartnern von GSF2 gesucht, die zur Aufklärung der Funktion von GSF2 beitragen beziehungsweise bisherige Forschungsergebnisse verifizieren sollten. Unter den nicht-essentiellen Genen der Hefe konnte allerdings kein synthetisch letaler oder synthetisch kranker Interaktionspartner von GSF2 ermittelt werden.
Im zweiten Projekt sollten Multicopy-Suppressoren aus einer Genbank identifiziert werden, die in der Lage sind die Deletion von GSF2 und damit verbundene Retention von Hxt1 in der Membran des Endoplasmatischen Retikulums zu komplementieren. Mit Hilfe dieses Screenings konnten einzig GSF2-kodierende Plasmide identifiziert werden.
Die Ergebnisse der beiden genetischen Screening-Verfahren belegen, dass Gsf2 eine herausragende Rolle innerhalb des Translokationsprozesses von Hxt1 einnimmt.
Struktur-Funktionsbeziehungen des Verpackungschaperons Gsf2 in der Hefe Saccharomyces cerevisiae
(2007)
Im Rahmen der vorliegenden Arbeit wurde die Funktion des in der Membran des Endoplasmatischen Retikulum lokalisierten Proteins Gsf2 der Hefe Saccharomyces cerevisiae näher charakterisiert. Gsf2 ist ein 46 kDa großes ER-Transmembranprotein mit zwei membrandurchspannenden Domänen, wobei C- und N-Terminus cytosolisch orientiert sind. Zudem besitzt Gsf2 C-terminal ein klassisches Dilysin-Motiv. Eine Deletion des GSF2-Gens resultiert in einer Retention der Hexosetransporter Hxt1, Hxt3 und Gal2 im ER, so dass es sich bei Gsf2 möglicherweise um ein Hexosetransporterspezifisches Verpackungschaperon handelt.
Um Sequenzbereiche zu determinieren, die für die Funktion des Verpackungschaperons bezüglich der Reifung und des ER-Transportes von Hxt1 notwendig sind, wurden verkürzte Versionen des Gsf2-Proteins hergestellt. Die funktionelle Analyse zahlreicher verkürzter Versionen ergab die Lokalisation eines essentiellen Sequenzbereiches in den hinteren 40 Aminosäuren der carboxyterminalen Domäne des Gsf2-Proteins.
Vorläufige genetische und biochemische Untersuchungen hatten ergeben, dass Gsf2 mit Komponenten der Ribosomen, des Sec61-Translokationsapparates und mit Proteinen der COPII-Vesikel interagiert.
Mit Hilfe des Split-Ubiquitin Systems konnte in der vorliegenden Arbeit eine direkte Interaktion zwischen Gsf2 und dem Sec61-Translokations-Komplex und den Komponenten des sekretorischen Weges Sec12 und Sar1 bestimmt werden. Sec12 ist ein Sar1-spezifischer Guanin-Nucleotid-Austausch-Faktor, der für die Aktivierung von Sar1 benötigt wird. Sar1 ist ein kleines G-Protein, welches für die Initiation der COPII-Vesikelbildung benötigt wird. Sar1 ist aber auch für die Erkennung di-basische ER-Exportsignale spezifischer Cargo-Proteine zuständig. Diese Interaktion weist daraufhin, dass Gsf2 über solch ein Motiv verfügt und somit die Verpackung von Hxt1 in COPII-Vesikel gewährleisten könnte.
Postuliert wird ein Modell, wonach Gsf2 bereits eine wichtige Funktion bei der Translokation des Hexosetransporter Hxt1 in die ER-Membran übernimmt. Dabei interagiert Gsf2 mit dem Sec61-Translokon, um den Reifungsprozess der naszierenden Polypeptidkette des Metabolittransporters zu ermöglichen. Anschließend rekrutiert Gsf2 das gefaltete Proteine an Exit-Sites des Endoplasmatischen Retikulums. Es interagiert dort mit Sec12 und Sar1, so dass Gsf2 zusammen mit dem Hexosetransporter in die COPII-Vesikel verpackt und zum Golgi-Apparat transportiert wird. Aufgrund des ERRetentionssignals wird Gsf2 über COPI-Vesikel recycelt.
Dieses Modell impliziert, dass Hxt1 über kein ER-Exportsignal verfügt und daher Gsf2 als guide eine ausschlaggebende Funktion bei dessen Translokation übernimmt.
In view of a growing world population and the finite nature of fossil resources, the development of eco-friendly production processes is essential for the transition towards a sustainable industry. Methanol, which can be produced both petrochemically and from renewable resources, offers itself as bridging technology and attractive alternative raw material for biotechnological processes. This work describes developments for the progress of the well-studied methylotrophic α proteobacterium Methylorubrum extorquens AM1 towards an efficient methylotrophic cell factory. Although many homologous and heterologous production routes have already been described and realized for M. extorquens in a laboratory scale, no industrial process has yet been realized. Three major reasons can be identified for this: (1) A limited choice of tools for genetic modifications, (2) a lack of understanding of carbon fluxes and side reactions occurring in modified strains, such as product reimports, and (3) the lack of tailored production strains for profitable target products and optimized bioprocessing protocols. The aim of the present work was to achieve developments for the mentioned areas. As a model application, the high-level production of chiral dicarboxylic acids from the substrate methanol was chosen. Enantiomerically pure chiral compounds are of great interest, e.g., as building blocks for chiral drugs. The ethylmalonyl CoA metabolic pathway (EMCP) which is part of the primary metabolism of M. extorquens, harbors unique chiral CoA-ester intermediates. Their acid derivatives can be released by cleavage of the CoA-moiety using heterologous enzymes. The dicarboxylic acids 2 methylsuccinic acid and mesaconic acid were produced in a previous study by introducing the heterologous thioesterase YciA into M. extorquens. In the said study, a combined product titer of 0.65 g/L was obtained in shake flask experiments. These results serve as the basis for the developments in the present work.
First, the previously described reuptake of products was thoroughly investigated and dctA2, a gene encoding for an acid transporter, was identified as target for reducing the product reuptake. In addition, reuptake of mesaconic acid was prevented by converting it to (S)-citramalic acid, a product not metabolizable by M. extorquens, by the introduction of a heterologous mesaconase. Together with 2-methylsuccinic acid, for which a high enantiomeric excess of (S)-2-methylsuccinic acid was determined, a second chiral molecule was thus added to the product spectrum. For the release of dicarboxylic acid products, YciA, a broad-range thioesterase that accepts a variety of CoA-esters with different chain lengths as substrates, was chosen. The enzyme should theoretically be able to hydrolyze all CoA-esters of interest present in the EMCP. However, in culture supernatants of M. extorquens strains that were overexpressing the corresponding yciA gene, only mesaconic acid and 2 methylsuccinic acid could be detected. To expand the substrate spectrum of YciA thioesterase with respect to other EMCP intermediates, semi-rational enzyme engineering was attempted. Screening of the corresponding strains carrying the respective YciA variants did not result in strains capable of producing new dicarboxylic acid products. However, the experiments revealed an amino acid position that strongly affected the production of mesaconic acid and 2-methylsuccinic acid in vivo. By substituting the according amino acid in YciA, the maximum titers of mesaconic acid and 2-methylsuccinic acid could be increased substantially. Application of an improved thioesterase variant in a second E. coli-based process confirmed the enhanced activity of the enzyme. The desired extension of the product spectrum by another chiral molecule (2-hydroxy-3-methylsuccinic acid, presumably the (2S,3R)-form) was finally achieved by using an alternative thioesterase. Tailored fermentation strategies were developed for the high-level production of the above-mentioned products.
As second part of the work, two novel genetic tools for M. extorquens were developed and characterized. The pBBR1-derived plasmid pMis1_1B was shown to be stably maintained in M. extorquens cells. In addition, its suitability for co-transformations with other plasmids was demonstrated. The second tool, the cumate-inducible promoter Ps6, is tailored for expression of pathways with toxic products, as the transcription of genes controlled by Ps6 is strongly repressed in the absence of an inducer.
Overall, the present work demonstrates the enormous potential of using M. extorquens as a methylotrophic cell factory. In the applications shown, the biotechnological production of high-priced chiral molecules is combined with the use of an attractive alternative substrate. In addition, new achievements and approaches are presented to facilitate the development of future M. extorquens production strains.
Sphingolipids are not only structural components of cell membranes but can also act as signalling molecules in different pathways. Sphingolipid precursors, Ceramides (Cer), are synthesized de novo by six different synthases (CerS1-6) which generate Cer of different chain lengths. Cer can be further synthesized to glycosphingolipids and sphingomyelin. Cell membrane parts that are enriched in glycosphingolipids are so-called lipid rafts and can function as signalling platforms for different receptors, such like the T cell receptor (TCR). CD4+ T cells play a crucial role in the development of ulcerative colitis, a chronic inflammatory disease of the colon. As CerS3 expression was increased in the white blood cells of human colitis patients, the role of CerS3 in the TCR signalling and colitis was investigated in this dissertation. By lenti-viral transduction of a CerS3-shRNA into a CD4+ Jurkat cell line, it was shown that CerS3 has an impact on activated T cells. A decrease of different sphingolipids after T cell activation via CD2/3/28 activation beads and IL2 treatment was observed that was accompanied by an inhibition of Zap70 phosphorylation, an important protein of the TCR signalling. The impaired TCR signalling led to a diminished NFAT1 translocation into the nucleus which subsequently led to a reduced NFAT1- dependent TNFα release. Downregulation of CerS3 in primary CD4+ T cells, obtained from the blood of healthy volunteers, also showed a reduced release of pro-inflammatory cytokines after activation. This dissertation demonstrates a pivotal role for CerS3 in T cell function and highlights CerS3 as potential new target for T cell driven colitis.
For thousands of years, S. cerevisiae has been employed by humans in brewing and baking. Nowadays, this budding yeast is more than that: it is a well investigated model organism and an established workhorse in biotechnology. S. cerevisiae serves as a production host for various applications such as i) bioethanol production ii) the biosynthesis of hormones including insulin or iii) cannabinoid biosynthesis. Hereby, the robustness of S. cerevisiae and its high tolerances regarding pH and salt concentrations qualifies it for a wide range of industrial applications. Moreover, products of S. cerevisiae are generally recognised as safe (GRAS), enabling diverse biotechnological applications. Various mechanisms for genetic engineering of S. cerevisiae are applicable and the engineering process itself is straightforward since methods are established and widely known. Due to the wide range of industrial applications of S. cerevisiae, this organism is an ideal candidate for applied research and implementation of the recombinant biosynthesis of tocochromanols in this study.
Tocochromanols encompass tocotrienols and tocopherols, which are lipid-soluble compounds that are commonly associated with vitamin E activity. Hereby, α-tocopherol is the most prevalent form, as it is an essential nutrient in the diet of humans and animals. Naturally, tocochromanols are almost exclusively synthesised by photoautotrophic organisms such as plants or cyanobacteria. They consist of an aromatic head group and a polyprenyl side chain which is saturated in tocopherols and 3-fold unsaturated in tocotrienols. The methylation status of the chromanol ring distinguishes α-, β-, γ- and δ-tocochromanol. All forms of tocochromanols represent a group of powerful antioxidants, scavenging reactive oxygen species (ROS) and preventing the propagation of lipid oxidation in lipophilic environments. Recently, attention has been drawn to tocotrienols, due to their benefits in neuroprotection as well as cholesterol-lowering and anti-cancer properties. Consequently, tocochromanols are valuable additives in the food, feed, cosmetic and pharmaceutical industries.
The metabolic engineering strategy of S. cerevisiae to enable tocochromanol biosynthesis was started in a preceding master thesis with the provision of the aromatic moiety, homogentisic acid (HGA), from the aromatic amino acid biosynthesis. Hereby, the upregulation and redirection of the native pathway was essential. Therefore, a strain with an engineered aromatic amino acid pathway for improved 4 hydroxyphenylpyruvate (HPP) production (MRY33) was utilised from Reifenrath and Boles (2018). Furthermore, a heterologous hydroxyphenylpyruvate dioxygenase (HPPD) was required to convert HPP into HGA. Thus, several heterologous HPPDs were expressed and characterised regarding their HGA production within the previous study. The best variant originated from Yarrowia lipolytica, YlHPPD, and was integrated into the genome of MRY33. The resulting strain JBY2, produced 435 mg/L HGA in a shake flask fermentation.
This work was started with the genetically highly modified strain JBY2, whose genome already contained a large number of genes artificially expressed behind strong promoters. For further strain development, it was advantageous to maintain a high degree of sequence variability in order to prevent genomic instabilities due to sequence homologies. Thus, 17 artificial promoters (AP1-AP17) were characterised regarding their strength of expression by the yellow fluorescent protein (YFP). These sequences were also part of a patent that was filed during this work (WO2023094429A1).
The key point of this study was the development of a metabolic engineering strategy for the strain JBY2. First, the sufficient supply of the second precursor, the polyprenyl side chain, was investigated. Natively, S. cerevisiae produces the precursor, geranylgeranyl diphosphate (GGPP), from the isopentenyl diphosphate pathway. However, without further engineering, GGPP was barely detectable in JBY2 (< 0.1 mg/L). Thus, engineering of the isopentenyl diphosphate biosynthesis was necessary. The limiting enzyme of the mevalonate pathway was the 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR), which is encoded by HMG1. Therefore, a truncation for feedback-resistance and its overexpression by a promoter exchange was performed. Furthermore, the promoter of the gene for the squalene synthase (pERG9) was exchanged by the ergosterol sensitive promoter pERG1 to limit the metabolic flux of the mevalonate pathway into the ergosterol pathway. The native GGPP synthase (BTS1) was another limitation that was observed throughout this study. To overcome this bottleneck, plasmid-based and integrative overexpression of the native BTS1 and a codon optimised BTS1 were investigated. Other strategies to improve GGPP production were the deletion of the gene for the diacylglycerol pyrophosphate phosphatase (DPP1) to prevent excessive dephosphorylation of GGPP to geranylgeraniol (GGOH), and the overexpression of the farnesyl pyrophosphate synthetase, encoded by ERG20. However, the best improvements of the GGPP biosynthesis, inferred through GGOH measurements, were achieved from the screening of several heterologous GGPP synthases in S. cerevisiae. The best performing strain was JBY61 (JBY2, hmg1Δ::pTDH3-HMG1tr[1573–3165], pERG9Δ::pERG1, ChrIV-49293-49345Δ::pTDH3-XdcrtE-tSSA1_LEU2), bearing the heterologous GGPP synthase crtE of Xanthophyllomyces dendrorhous and produced 64.23 mg/L GGOH. Consequently, this engineering strategy improved the GGOH production by a factor of 642 compared to the parent strain JBY2.
Terpenes are one of the largest and most diverse class of natural products, produced by organisms from all kingdoms of life and with important applications in the pharma, flavor and fragrance industries. Well-known examples of terpenes are the pharmaceuticals artemisinin and taxol, the flavor and fragrance compounds menthol, santalol and sclareol, the structural material polyisoprene and the biofuel precursor farnesene. The methods and results presented in this work offer a variety of ways to modify terpene precursors for the creation of new terpene molecules. The application of these methodologies in well-established production systems could lead to the production of new substances, with applications in the industrial fields of pharmaceuticals, flavors and fragrances, and biofuels.
Biotechnological processes offer better production conditions for a wide variety of goods of industrial interest. The production of aromatic compounds, for example, involves molecules of great value for cosmetic, plastic, agrochemical and pharmaceutic industries. However, the yield of such processes frequently prevents a proper implementtation that would allow the replacement of traditional production processes.
Numerous rational engineering approaches have been attempted to enhance metabolic pathways associated with desired products. Unfortunately, genetic modifications and heterologous pathway expression often lead to a higher metabolic burden on the producing organisms, ultimately leading to reduced production levels and fitness.
This project utilised adaptive laboratory evolution to better understand the development of synthetic cooperative consortia, using S. cerevisiae as a model organism. Specifically, a synthetic cooperative consortium was developed around the exchange of lysine and tyrosine, which was subjected to adaptive laboratory evolution aiming to induce mutations that would improve the system’s fitness either by enhanced production or upgraded stress resistance. Consequently, the mutant strains isolated after the evolution rounds were sequenced to identify relevant variations that could be related to the growth and production phenotypes observed.
The insights derived from this project are expected to contribute to further developing synthetic cooperative consortia with utilitarian purposes.